T1	HMM 25 46	cardiovascular events
T2	HMM 200 231	recurrent cardiovascular events
T3	HMM 889 1118	combined coronary events (coronary death, nonfatal MI, percutaneous transluminal coronary angioplasty [PTCA] or coronary artery bypass graft surgery [CABG]), the primary trial end point (coronary death or nonfatal MI) and stroke.
T4	HMM 1164 1178	risk reduction
T5	HMM 1411 1415	risk
T6	HMM 1475 1488	plasma lipids
T7	HMM 1546 1569	risk of coronary events
T8	HMM 1786 1790	CABG
T9	HMM 1883 1904	cardiovascular events
